The epidemiology of pyogenic liver abscess has changed dramatically in recent years ([@R1]). Previously, although incidence was considered rare, the condition was associated with high illness and death rates, usually due to underlying hepatobiliary diseases and polymicrobial infection ([@R2]), with *Escherichia coli* as the major pathogen ([@R3]). More recently, investigations in Taiwan suggest the role of cryptogenic or primary liver abscess, i.e., abscesses without underlying hepatobiliary diseases, in pyogenic liver abscess ([@R4]*,*[@R5]). These reports also indicate that diabetes is the major predisposing factor of liver abscess and that *Klebsiella* *pneumoniae* is the primary pathogen. However, these results were obtained from small-scale hospital-based surveys, which could not provide a panoramic view of the disease. To confirm these observation-based results, we conducted a large-scale, unbiased investigation.

In addition to epidemiology, the pathogenesis of liver abscess caused by *Klebsiella* spp. has also been extensively studied, but the mechanism is still not clear. MagA, an outer-membrane protein contributing to capsular polysaccharide formation, coexists with serotype K1 and has been identified as the major virulence factor of *K.* *pneumoniae* ([@R6]). MagA-positive (or serotype K1) *K.* *pneumoniae* is accordingly recognized as the main pathogen of pyogenic liver abscess ([@R7]*,*[@R8]). Nevertheless, how diabetes increases the risk for *Klebsiella* spp. liver abscess is still not clear. Further research is needed on whether pyogenic liver abscess is affected by immunocompromised conditions, such as malignancy, renal failure, postorgan transplantation, or HIV infection.

To clarify the epidemiology and pathogenesis of pyogenic liver abscess, we used information gathered by the Taiwan National Health Insurance (NHI) program, which was initiated in 1995 by the government to cover most Taiwanese citizens. In 2005, 91.25% of healthcare providers were enrolled in the program and 99% of Taiwanese were insured ([@R9]). Consequently, since 1995, the program has obtained comprehensive health data on the population in Taiwan. In this study, we used NHI data to study the incidence and death rates caused by pyogenic liver abscess in Taiwan and to investigate factors modifying the manifestations of this disease.

Methods
=======

Patients
--------

We requested data on patients with pyogenic liver abscess from the Taiwan NHI program. Cases were selected by using the following criteria: patients were hospitalized and reported before 2004, and the discharge diagnoses included abscess of liver per the International Classification of Diseases, 9th revision, Clinical Modication (ICD-9-CM 572.0) but excluded amebic liver abscess (ICD-9-CM 006.3). Though we selected cases documented up to the end of 2004, the database could not provide information from patients who had not yet been discharged. Those admitted before December 31, 2004, but discharged during or after 2005 were therefore not included in our database. This exclusion results in the underestimation of case-patients admitted at the end of 2004.

Data on 29,965 case-patients were collected. After excluding patients discharged before 1996 and those without clear records regarding age or sex, we enrolled 29,703 case-patients in our study. Patient data were anonymous. Names of these patients were not included, and patient and healthcare provider identification numbers were encrypted.

This primary set of data included the date of admission and discharge, age, sex, diagnoses (up to 5), procedures (up to 5), outcome at discharge (recovered or died), and the fees charged to patients. Laboratory data, including microbiologic data and medication, were not included. Any underlying diseases were determined by the diagnoses listed in the medical records, which were coded by ICD-9-CM.

Because *K*. *pneumoniae* is the major pathogen of primary pyogenic liver abscess in Taiwan, it is expected to play an important role in the pathogenesis and prognosis of this disease. Unfortunately, the NHI database does not include microbiologic data. To compensate for this, we reviewed the records of patients in National Taiwan University Hospital (NTUH). This hospital is a public medical center in Taipei, functioning both as a primary care hospital and as a tertiary referral center ([@R10]). As the leading hospital in Taiwan ([@R10]) with a 113-year history ([@R11]), NTUH serves patients and accepts referrals evenly distributed from every part of Taiwan. The hospital provides care for ≈2,000 inpatients and 7,000 outpatients a day ([@R11]), which are ≈3.5% and 2%, respectively, of persons included in the NHI database ([@R12]). Therefore, the patients of NTUH are representative of all of the patients in Taiwan, without substantial bias but may be skewed slightly to the severe side. We selected case-patients from this hospital using the same criteria mentioned above, except that the discharge year was between January 1, 2000, and December 31, 2004; complete microbiologic data was preserved in the NTUH laboratory only after 2000. These patients were included in the NHI database anonymously. For case-patients from NTUH, we reviewed actual medical records and obtained microbiologic data from the hospital's laboratory.

Statistical Analysis
--------------------

Numerical data were compared by Student *t* test or paired *t* test. Categorical data were processed by χ^2^ test. Pearson correlation coefficients and χ^2^ goodness-of-fit test were used to estimate the trend of incidence and death over time. Unfortunately, incidence and death from different years could not be directly compared because the population structure changed slightly over the study period. To correct the bias, we calculated age-standardized incidence and death rates. The correction was based on age-specific population data in 1996. Finally, risk factor analysis was conducted by using the binary logistic regression and curve estimation methods by SPSS version 11.0 for Macintosh (SPSS, Inc. Chicago, IL, USA).

Results
=======

Demographic Data
----------------

A total of 29,703 case-patients from the NHI database were enrolled in our analysis ([Table 1](#T1){ref-type="table"}). Ages of these patients ranged from \<1 through 106 years of age, with a median age of 61 years; a total of 9,904 (33.3%) had diabetes mellitus, 3,079 (10.4%) had cirrhosis of the liver, 4,350 (14.6%) had cholelithiasis, and 4,115 (13.9%) had concomitant malignancy.

###### Demographic data from National Health Insurance database, Taiwan, 1996--2004

  Item                                Female           Male             Total            p value\*
  ----------------------------------- ---------------- ---------------- ---------------- -----------
  Sex, no. (%)                        11,377 (38.3)    18,326 (61.7)    29,703 (100)     
  Age: range (median), y              0--106 (63.90)   0--101 (58.98)   0--106 (61.00)   \<0.001†
  Age: mean (SD), y                   62.13 (14.87)    57.58 (16.03)    59.32 (15.75)    \<0.001‡
  Hospitalization: mean (SD), d       18.00 (13.80)    16.91 (12.74)    17.33 (13.17)    \<0.001‡
  Diabetes mellitus, no. (%)          3,998 (35.1)     5,906 (32.2)     9,904 (33.3)     \<0.001§
  Cirrhosis, no. (%)                  854 (7.5)        2,225 (12.1)     3,079 (10.4)     \<0.001§
  Renal disease, no. (%)              772 (6.8)        1,191 (6.5)      1,963 (6.6)      0.334§
  Hypertension, no. (%)               1,491 (13.1)     1,866 (10.2)     3,357 (11.3)     \<0.001§
  Heart disease, no. (%)              826 (7.3)        1,118 (6.1)      1,944 (6.5)      \<0.001§
  Cerebrovascular accident, no. (%)   364 (3.2)        454 (2.5)        818 (2.8)        \<0.001§
  Cholelithiasis, no. (%)             2,121 (18.6)     2,229 (12.2)     4,350 (14.6)     \<0.001§
  Hepatobiliary malignancy, no. (%)   863 (7.6)        1,769 (9.7)      2,632 (8.9)      \<0.001§
  Other malignancy, no. (%)           546 (4.8)        937 (5.1)        1,483 (5.0)      0.227§
  Pneumonia, no. (%)                  675 (5.9)        1,273 (6.9)      1,948 (6.6)      0.001§
  Urinary tract infection, no. (%)    923 (8.1)        697 (3.8)        1,620 (5.5)      \<0.001§
  Acute viral hepatitis, no. (%)      228 (2.0)        657 (3.6)        885 (3.0)        \<0.001§
  Peptic ulcer, no. (%)               985 (8.7)        1,623 (8.9)      2,608 (8.8)      0.557§
  Abscess drainage no. (%)            3,886 (34.2)     6,082 (33.2)     9,968 (33.6)     0.082§
  Biliary procedure no. (%)           1,967 (17.3)     2,361 (12.9)     4,328 (14.6)     \<0.001§
  Deaths, no. (%)                     1,286 (11.3)     1,954 (10.7)     3,240 (10.9)     0.085§

\*p\<0.05 is considered statistically significant. †Mann-Whitney U test. ‡Student *t* test. §χ^2^ test.

Average hospitalization was 17.33 days. The proportions of patients who received abscess drainage and biliary procedures (endoscopic or surgical biliary drainage) were 33.6% and 14.6%, respectively. The death rate was 10.9%.

Male patients dominated the sample population (18,326/29,703, 61.7%) and, on average, were 5 years younger than their female counterparts (57.58 ± 16.03 vs. 62.13 ± 14.87 years, p*\<*0.001). Besides the difference in age, more female patients had concomitant cholelithiasis (18.6% vs. 12.2%, p*\<*0.001). Female patients also received biliary procedures more often (17.3% vs. 12.9%, p*\<*0.001) than did male patients.

We then investigated the data over time. An average of 3,300 cases/year or 275 cases/month were reported. The number of reported cases increased from 2,400 in 1996 to 3,991 in 2004 ([Table 2](#T2){ref-type="table"}), with a stable increase rate of 1.44 more new cases per month ([Figure 1](#F1){ref-type="fig"}); the decline in cases at the end of 2004 is possibly due to the incomplete recruitment of cases as described in the Methods section.

###### Incidence rates and deaths from pyogenic liver abscess, National Health Insurance database, Taiwan, 1996--2004\*

  Year       Case-patients with pyogenic liver abscess                  Deaths from pyogenic liver abscess                                
  ---------- ------------------------------------------- -------------- ------------------------------------ -- ------------ ------------ ------------
  1996       945 (9.03)                                  1455 (13.15)   2400 (11.15)                            112 (1.07)   184 (1.66)   296 (1.38)
  1997       1045 (9.88)                                 1562 (13.99)   2607 (11.99)                            135 (1.28)   173 (1.55)   308 (1.42)
  1998       1130 (10.58)                                1701 (15.13)   2831 (12.91)                            151 (1.41)   189 (1.68)   340 (1.55)
  1999       1162 (10.78)                                1936 (17.11)   3098 (14.02)                            138 (1.28)   213 (1.88)   351 (1.59)
  2000       1300 (11.94)                                2094 (18.38)   3394 (15.24)                            147 (1.35)   201 (1.76)   348 (1.56)
  2001       1453 (13.25)                                2218 (19.39)   3671 (16.38)                            160 (1.46)   258 (2.25)   418 (1.87)
  2002       1406 (12.74)                                2485 (21.64)   3891 (17.28)                            151 (1.37)   259 (2.26)   410 (1.82)
  2003       1434 (12.93)                                2386 (20.72)   3820 (16.90)                            143 (1.29)   238 (2.07)   381 (1.69)
  2004       1502 (13.47)                                2489 (21.57)   3991 (17.59)                            149 (1.34)   239 (2.07)   388 (1.71)
  p value†   \<0.001                                     \<0.001        \<0.001                                 0.224        \<0.001      \<0.001

\*Data are presented as number (rate per 100,000 population). †χ^2^ goodness-of-fit test. p\<0.05 is considered statistically significant.

![Number of new reported cases of pyogenic liver abscess recorded monthly in the National Health Insurance database, Taiwan, January 1996 through December 2004.](07-1254-F1){#F1}

The annual number of case-patients increased with age; peak incidence for women was seen in those 60--64 years of age and in men 65--69 years of age. A slight decline was noted in case-patients 55--59 years of age, a reflection of decreased birth rates during World War II. Men \<85 years of age had more liver abscess than women but the opposite result was seen in women \>85 years of age.

Incidence and Risk Factors
--------------------------

The gross incidence of pyogenic liver abscess from 1996 through 2004 was 14.87 cases/100,000 population/year (17.94 male cases/100,000 population and 11.65 female cases/100,000 population). The annual increase of incidence was 0.86 cases/100,000 population (*r =* 0.98, p*\<*0.001) ([Figure 2](#F2){ref-type="fig"}, panel **A**). When we calculated age-standardized incidences, the increase rate was 0.51 cases/100,000 population/year (*r =* 0.92, p*\<*0.001) ([Figure 2](#F2){ref-type="fig"}, panel **B**). The age of highest incidence in men was in those 80--84 years of age (86.71 cases/100,000 population); for women, the highest incidence was in those 85--89 years of age (79.80 cases/100,000 population).

![Incidence of pyogenic liver abscess in Taiwan, showing a steady increase from 1996 to 2004. The incidence is expressed as the number of new cases reported from the population (the National Health Insurance database) per year. A) The linear increase of the primary incidence data (raw incidence) with the year can be described by this formula: incidence (×1/100,000) = 0.860 × year -- 1704.66 (*r* = 0.978, p\<0.001). B) The linear increase of the standardized incidence data (the incidence normalized according to the age distribution of the population) with the year can be described by this formula: incidence (×1/100,000) = 0.512 × year -- 1010.68 (*r* = 0.923, p\<0.001). *r*, Pearson correlation coefficient.](07-1254-F2){#F2}

Several factors were associated with the increased incidence of liver abscess. Because incidence data from each year could not be merged directly, we chose the cases reported in 2004 to evaluate the relative risk for each factor ([Table 3](#T3){ref-type="table"}). Diabetes mellitus and malignancy were associated with a ≈10-fold increased risk, while renal disease and pneumonia tripled and quadrupled the incidence of liver abscess, respectively. We did not investigate the interactions among these factors because it required detailed health records of each person in the Taiwan population, which would violate patient confidentiality regulations.

###### Factors associated with increased incidence in pyogenic liver abscess based on cases reported in the National Health Insurance database, Taiwan, 2004\*

  Factor                  Incidence with factor   Incidence without factor   Relative risk (95% CI)
  ----------------------- ----------------------- -------------------------- -------------------------
  Sex (M)                 21,565                  13,474                     1.601  (1.501--1.707)
  Acute viral hepatitis   50,798                  17,090                     2.973  (2.511--3.466)
  Diabetes mellitus       111,998                 12,322                     9.098  (8.520--9.716)
  Malignancy              162,610                 15,176                     10.731  (9.840--11.702)
  Hypertension            23,989                  16,772                     1.430  (1.313--1.559)
  CVA                     22,756                  17,471                     1.303  (1.083--1.567)
  Pneumonia               77,048                  16,541                     4.661  (4.145--5.240)
  Renal disease           62,795                  16,878                     3.722  (3.250--4.263)
  Heart disease           19,494                  17,468                     1.116  (0.986--1.264)

\*Incidence is expressed as cases/100,000 population. CI, confidence interval; CVA, cerebrovascular accident.

Change in Death Rates
---------------------

In contrast to increased incidence rates from 1996 through 2004, the disease-specific death rate declined steadily from 12.33% in 1996 to 9.72% in 2004 while the number of deaths caused by pyogenic liver abscess increased slightly over this same timeframe ([Figure 2](#F2){ref-type="fig"}, panel **B**). The yearly change in the death rate was --0.31% (*r =* 0.91, p*\<*0.001) ([Figure 3](#F3){ref-type="fig"}, panel **A**). When we calculated age-standardized death rates, the decrease was 0.38%/year (*r =* 0.94, p*\<*0.001) ([Figure 3](#F3){ref-type="fig"}, panel **B**). Death rates did not differ much between males and females (10.7% vs. 11.3%) ([Table 1](#T1){ref-type="table"}). Death rates increased slowly for men and women 35--85 years of age and peaked for those 90--94 years of age (33.81%). Minor peaks were noted for adolescents 10--14 years of age (19.35%) and for young men 20--24 years of age (12.36%), respectively.

![Deaths from pyogenic liver abscess in Taiwan, showing a steady decrease from 1996 to 2004. Mortality rate is expressed as the number of deaths reported from pyogenic liver abscess cases per year. A) The linear decrease of the primary mortality data (raw mortality) with the year can be described with this formula: mortality (×1/100) = −0.314 × year + 639.58 (*r* = 0.910, p\<0.001). B) The linear decrease of the standardized mortality data (the mortality normalized according to the age distribution of the population) with the year can be described with this formula: mortality (×1/100) = −0.383 × year +776.59 (*r* = 0.944, p\<0.001). *r*, Pearson correlation coefficient. p\<0.05 is considered statistically significant.](07-1254-F3){#F3}

We tested case-patients with binary logistic regression to identify the factors contributing to increased death rates ([Table 4](#T4){ref-type="table"}). Multivariate analysis showed an increased risk of 1.7%/year of age. Renal disease and malignancy were respectively associated with a 2.5- and a 2-fold increased risk, followed by pneumonia (1.5-fold) and heart disease (1.3-fold). Some underlying diseases were associated with a lower risk for death, including diabetes (0.85-fold), peptic ulcer (0.75- fold), urinary tract infection (0.74-fold), hypertension (0.44-fold), and cholelithiasis (0.69-fold). Therapeutic procedures were also related to the lower risk of death (abscess drainage 0.57-fold, biliary drainage 0.73-fold), compatible with our expectations.

###### Binary logistic regression analysis showing factors associated with death from pyogenic liver abscess, Taiwan, 1996--2004\*

  Factor                     Univariate analysis             Multivariate analysis                        
  -------------------------- --------------------- --------- ----------------------- -- ------- --------- --------------
  Age, y                     1.018                 \<0.001   1.015--1.020               1.017   \<0.001   1.015--1.020
  Sex (M)                    0.937                 0.085     0.869--1.009               0.930   0.067     0.861--1.005
  Diabetes mellitus          0.813                 \<0.001   0.750--0.880               0.850   \<0.001   0.782--0.925
  Abscess drainage           0.541                 \<0.001   0.497--0.590               0.571   \<0.001   0.523--0.624
  Biliary procedure          0.635                 \<0.001   0.564--0.715               0.728   \<0.001   0.640--0.828
  Peptic ulcer               0.778                 \<0.001   0.676--0.895               0.751   \<0.001   0.651--0.867
  Urinary tract infection    0.851                 0.063     0.718--1.009               0.735   0.001     0.617--0.875
  Cirrhosis                  1.027                 0.663     0.912--1.156               --      --        --
  Renal disease              2.599                 \<0.001   2.322--2.909               2.452   \<0.001   2.181--2.756
  Hypertension               0.480                 \<0.001   0.414--0.557               0.435   \<0.001   0.374--0.506
  Cerebrovascular accident   1.405                 0.001     1.153--1.713               1.219   0.058     0.993--1.497
  Cholelithiasis             0.599                 \<0.001   0.530--0.676               0.693   \<0.001   0.608--0.790
  Hepatobiliary malignancy   1.745                 \<0.001   1.564--1.947               1.850   \<0.001   1.646--2.080
  Other malignancy           2.151                 \<0.001   1.883--2.456               2.136   \<0.001   1.859--2.454
  Pneumonia                  1.770                 \<0.001   1.563--2.003               1.516   \<0.001   1.333--1.723
  Acute viral hepatitis      0.481                 \<0.001   0.361--0.642               0.431   \<0.001   0.321--0.578
  Heart disease              1.384                 \<0.001   1.212--1.581               1.254   0.001     1.092--1.440

\*CI, confidence interval. †p\<0.05 is considered statistically significant.

*K. pneumoniae* and Pyogenic Liver Abscess at NTUH
--------------------------------------------------

To compensate for the deficiency of microbiologic data in the NHI database, we reviewed the medical records of case-patients with primary pyogenic liver abscess admitted to NTUH from 2000 through 2004. In total, 506 case-patients were enrolled, ≈3.70% of all case-patients in Taiwan (13,672) during the same period. This ratio is similar to the general NTUH: Taiwan inpatient ratio (3.50%) ([@R12]), suggesting that liver-abscess cases in NTUH are probably a microcosm for the liver-abscess patients in all of Taiwan. Demographic data are shown in [Table 5](#T5){ref-type="table"}. Compared with the NHI database, case-patients in NTUH had longer hospitalization periods and higher frequencies of heart disease and malignancy, implying severe underlying conditions. However, the ratios of sepsis, meningitis, endophthalmitis, and pneumonia were similar between NTUH and Taiwan data, so the severity of primary liver abscess in NTUH patients and Taiwan as a whole were equal. Besides, NTUH case-patients were associated with higher rates of abscess drainage and lower death rates, indicating that the quality of medical care for those patients is probably better than the average level of medical care provided in Taiwan.

###### Demographic data on patients with primary pyogenic liver abscess from NTUH and NHI databases, Taiwan, 2000--2004\*

  Item                                NHI database              NTUH                  p value†
  ----------------------------------- ------------------------- --------------------- ----------
  Total no. case-patients             13,672                    506 (3.70)            
  Age, y, range (median)              0--100 (59.95)            0--90 (57.50)         
  Age, y, mean (SD)                   58.31 (16.37)             55.92 (16.93)         0.001
  Hospitalization, mean (SD)          17.32 (12.80)             30.13 (34.08)         \<0.001
  M/F, no. (%)                        8,652/5,020 (63.3/36.7)   329/177 (65.0/35.0)   0.426
  Diabetes mellitus, no. (%)          5,428 (39.7)              140 (27.7)            \<0.001
  Cirrhosis, no. (%)                  1,153 (8.4)               19 (3.8)              \<0.001
  Renal disease, no. (%)              1,113 (8.1)               47 (9.3)              0.355
  Hypertension, no. (%)               1,947 (14.2)              88 (17.4)             0.047
  Heart disease, no. (%)              1,038 (7.6)               53 (10.5)             0.017
  Cerebrovascular accident, no. (%)   461 (3.4)                 17 (3.4)              0.988
  Other malignancy, no. (%)           930 (6.8)                 77 (15.2)             \<0.001
  Sepsis, no. (%)                     3,252 (23.8)              137 (27.1)            0.089
  Meningitis, no. (%)                 155 (1.1)                 6 (1.2)               1.000
  Endophthalmitis, no. (%)            226 (1.7)                 10 (2.0)              0.593
  Pneumonia, no. (%)                  1,141 (8.3)               54 (10.7)             0.064
  Urinary tract infection, no. (%)    916 (6.7)                 20 (4.0)              0.015
  Acute viral hepatitis, no. (%)      400 (2.9)                 10 (2.0)              0.211
  Peptic ulcer, no. (%)               1,161 (8.5)               20 (4.0)              \<0.001
  Abscess drainage, no. (%)           4,795 (35.1)              292 (57.7)            \<0.001
  Biliary procedure, no. (%)          790 (5.8)                 15 (3.0)              0.007
  Deaths, no. (%)                     1,410 (10.3)              31 (6.1)              0.002

\*Data expressions and statistical methods in this table are the same as in [Table 1](#T1){ref-type="table"}. NTUH, National Taiwan University Hospital; NHI, National Health Insurance. †p\<0.05 is considered statistically significant.

Among the 506 cases, 358 had positive culture results ([Table 6](#T6){ref-type="table"}), and 286 (79.9%) of 358 case-patients showed *K*. *pneumoniae* infection. Patients with *Klebsiella* spp. infection had a lower death rate (2.4% vs. 11.1%; p *=* 0.004), less mixed bacterial infection (4.5% vs. 26.4%; p*\<*0.001), and less underlying malignancy (5.2% vs. 20.8%; p*\<*0.001). Of case-patients with *Klebsiella* spp. liver abscess, 35% were associated with diabetes mellitus. The prevalence of diabetes in case-patients with other micromicrobial infections was 18.1% (p *=* 0.007). Binary logistic regression analysis showed that *Klebsiella* spp. infection was associated with decreased death rates (relative risk 0.20, p *=* 0.003); the role of diabetes was neutral (relative risk 1.09, p *=* 0.88) ([Table 7](#T7){ref-type="table"}). Therefore, the low death rates in case-patients with diabetes who also had liver abscess were probably attributed to *Klebsiella* spp. infection.

###### *Klebsiella* spp. liver abscess compared with other primary pyogenic liver abscess, NTUH, Taiwan, 1996--2004\*

  Item                                *Klebsiella* spp.   Non-*Klebsiella* spp.   p value†
  ----------------------------------- ------------------- ----------------------- ----------
  Total no.                           286                 72                      
  Male gender, no. (%)                191 (66.8)          45 (62.5)               0.490
  Deaths, no. (%)                     7 (2.4)             8 (11.1)                0.004
  Abscess drainage, no. (%)           204 (71.3)          49 (68.1)               0.664
  Biliary procedure, no. (%)          2 (0.7)             9 (12.5)                \<0.001
  Mixed infection, no. (%)            13 (4.5)            19 (26.4)               \<0.001
  Diabetes mellitus, no. (%)          100 (35.0)          13 (18.1)               0.007
  Peptic ulcer, no. (%)               10 (3.5)            7 (9.7)                 0.055
  Urinary tract infectio, no. (%)     14 (4.9)            2 (2.8)                 0.749
  Renal disease, no. (%)              25 (8.7)            6 (8.3)                 1.000
  Hypertension, no. (%)               55 (19.2)           14 (19.4)               1.000
  Heart disease, no. (%)              28 (9.8)            9 (12.5)                0.517
  Cerebrovascular accident, no. (%)   7 (2.4)             3 (4.2)                 0.427
  Malignancy, no. (%)                 15 (5.2)            15 (20.8)               \<0.001
  Cirrhosis, no. (%)                  5 (1.7)             2 (2.8)                 0.632
  Pneumonia, no. (%)                  35 (12.2)           6 (8.3)                 0.414
  Viral hepatitis, no. (%)            4 (1.4)             1 (1.4)                 1.000
  Meningitis, no. (%)                 3 (1.0)             0 (0.0)                 0.613
  Endophthalmitis                     9 (3.1)             0 (0.0)                 0.214
  Age, y, mean (SD)                   57.39 (15.52)       55.25 (19.26)           0.384
  No. hospitalizations, mean (SD)     26.12 (16.36)       43.06 (69.64)           0.044

\*NTUH, National Taiwan University Hospital. The χ^2^ test and Student *t* test were used for statistical analyses. †p\<0.05 is considered statistically significant.

###### Factors modifying the death rates from primary pyogenic liver abscess analyzed by binary logistic regression, NTUH, Taiwan, 2000--2004\*

  Factor                 Univariate analysis           Multivariate analysis                      
  ---------------------- --------------------- ------- ----------------------- -- ------- ------- ---------------
  Age                    1.034                 0.074   0.997--1.073               --      --      --
  Gender                 0.436                 0.117   0.154--1.231               --      --      --
  *Klebsiella*           0.201                 0.003   0.070--0.574               0.223   0.009   0.072--0.690
  Diabetes mellitus      1.088                 0.880   0.363--3.260               --      --      --
  Renal disease          4.256                 0.019   1.269--14.271              6.172   0.006   1.665--22.884
  Heart disease          1.354                 0.698   0.293--6.247               --      --      --
  Malignancy             4.433                 0.016   1.319--14.900              2.922   0.119   0.759--11.254
  Cirrhosis              4.012                 0.212   0.452--35.613              --      --      --
  Abscess drainage       0.345                 0.045   0.122--0.977               0.351   0.063   0.116--1.060
  Hospitalization days   1.002                 0.793   0.990--1.013               --      --      --

\*NTUH, National Taiwan University Hospital; CI, confidence interval. †p\<0.05 is considered statistically significant.

Discussion
==========

We present a nationwide population-based report of pyogenic liver abscess in Taiwan. Taiwan started the NHI program in 1995, with a coverage rate of ≈99% of its population. By providing national healthcare, the system collected medical records from virtually every person seeking medical help in Taiwan so many nationwide surveys were automatically completed. The database, therefore, reflects a complete and unbiased picture of general health conditions in Taiwan.

Our data suggests Taiwan is endemic for pyogenic liver abscess. This disease had been considered rare in the past; previous reports showed an annual incidence rate of 2.3/100,000 ([@R13]) and 1.0/100,000 ([@R14]) in Canada and Denmark, respectively. In our report, however, the incidence rate was 10× higher (11.99/100,000 in 1996 and up to 17.59/100,000 in 2004). Such high incidence rates and rapid increase indicate the true growth of this disease because the data could not be explained solely by the change in population structure or by improved detection capacity of medical professionals. First, the diagnostic tools and methods for pyogenic liver abscess did not remarkably change during our study. Furthermore, the incidence did not explode but increased steadily over time. Thus, the increase is unlikely to have been caused by improved diagnostic sensitivity. Second, to eliminate bias induced by the change in population structure over time, we calculated age-standardized incidence. The increased incidence remains significant after correction ([Figure 2](#F2){ref-type="fig"}, panels **A**, **B**). Hence, endemic pyogenic liver abscess possibly existed long before these data were first collected in Taiwan, even though the situation has recently become much worse. During the study period, magA-positive *K*. *pneumoniae* was identified as the major cause of pyogenic liver abscess in Taiwan ([@R6]*,*[@R15]). Although culture data were lacking in the NHI database, 80% of NTUH case-patients had positive culture data that showed *Klebsiella* spp. A recent nationwide report from South Korea also showed that the proportion of *K*. *pneumoniae* infection increased dramatically in that country over time from ≈0% in 1955--1969 up to 78.2% during 2004--2005 ([@R8]). We can therefore infer that the high incidence of pyogenic liver abscess in Taiwan is related to *Klebsiella* spp. infection.

In contrast to the rise of incidence over time, death rates from pyogenic liver abscess decreased. In our analysis, the death rate from pyogenic liver abscess in Taiwan was 10.9% during 1996--2004 ([Table 1](#T1){ref-type="table"}) while the inhospital death rate was 6.1% ([Table 5](#T5){ref-type="table"}). These rates are much lower than those in earlier reports, 25% ([@R16]) to 50% ([@R14]), but are consistent with those in more recent reports, in which population-based death rates were ≈10% ([@R13]*,*[@R14]) while inhospital death rates ranged from 6%--8% ([@R15]*,*[@R17]*,*[@R18]). This decrease might be multifactorial.

First, the decrease in death rates might be the result of the dramatic increase of case-patients with pyogenic liver abscess. In a previous report, Jepsen et al. suggested that the dramatic decrease in death rates in Denmark between 1977 and 2002 resulted from improved diagnostic tools ([@R14]). This reason might also apply in Taiwan because the liver abscess--related death rate in the general population actually increased from 1.38/100,000 in 1996 to 1.80/100,000 in 2004. However, the increase was not steady, with a peak of 1.94/100,000 in 2001 followed by a decrease, indicating a true decrease of disease-specific deaths. Thus, diagnostic sensitivity could not explain the whole condition.

Second, the advance of medical care might have contributed to the decrease in mortality rates. Because abscess drainage was reported to improve the outcome ([@R2]*,*[@R15]*,*[@R19]) and *Klebsiella* spp. was associated with a relatively benign course under aggressive medical care ([@R5]*,*[@R20]), we hypothesized that the decrease in death rates was due to the increase of *Klebsiella* spp. infection and the increase of abscess drainage. To test this hypothesis, we calculated the trends of death-related factors over time in the NHI database. As indicated in [Table 8](#T8){ref-type="table"}, the decrease in death rates was chronologically compatible with the increase of abscess drainage (+1.38% per year, *r =* 0.88, p *=* 0.002). Although the database did not include culture data, the annual increase of diabetes (+0.69%, *r =* 0.86, p *=* 0.003) and pneumonia (+0.28%, *r =* 0.90, p *=* 0.001) suggested the concomitant annual increase of *Klebsiella* spp. infection. Therefore, the significant decrease of liver abscess-related deaths in recent years is caused by a microbiologic shift (more *Klebsiella* spp. infections) and better medical care (more abscess drainage).

###### Chronological changes of factors associated with pyogenic liver abscess, NHI database, Taiwan, 1996--2004\*

  Year (no. cases)   Abscess drainage, no. (%)   Biliary procedure, no. (%)   Renal disease, no. (%)   Diabetes mellitus, no. (%)   Hepatobiliary malignancy, no. (%)   Other malignancy, no. (%)   Pneumonia, no. (%)   Heart disease, no. (%)   Deaths, no. (%)
  ------------------ --------------------------- ---------------------------- ------------------------ ---------------------------- ----------------------------------- --------------------------- -------------------- ------------------------ -----------------
  1996 (2,400)       589 (24.5)                  316  (13.2)                  123  (5.1)               696  (29)                    149  (6.2)                          81  (3.4)                   132  (5.5)           137  (5.7)               296 (12.3)
  1997 (2,607)       729  (28)                   389  (14.9)                  156  (6)                 819  (31.4)                  210  (8.1)                          106  (4.1)                  155  (5.9)           154  (5.9)               308 (11.8)
  1998 (1,831)       932 (32.9)                  473  (16.7)                  161  (5.7)               911  (32.2)                  276  (9.7)                          124  (4.4)                  168  (5.9)           186  (6.6)               340 (12)
  1999 (3,098)       1,055 (34.1)                480  (15.5)                  198  (6.4)               1,005 (32.4)                 302  (9.7)                          137  (4.4)                  179  (5.8)           194  (6.3)               351 (11.3)
  2000 (3,394)       1,190 (35.1)                484  (14.3)                  258  (7.6)               1,139 (33.6)                 292  (8.6)                          171 (5)                     193  (5.7)           198  (5.8)               348 (10.3)
  2001 (3,671)       1,233 (33.6)                515  (14)                    286  (7.8)               1,241 (33.8)                 340  (9.3)                          203  (5.5)                  246  (6.7)           254  (6.9)               418 (11.4)
  2002 (3,891)       1,355 (34.8)                604  (15.5)                  279  (7.2)               1,339 (34.4)                 372  (9.6)                          206  (5.3)                  290  (7.5)           264  (6.8)               410 (10.5)
  2003 (3,820)       1,387 (36.3)                519  (13.6)                  281  (7.4)               1,411 (36.9)                 347  (9.1)                          195  (5.1)                  282  (7.4)           290  (7.6)               381 (10.0)
  2004 (3,991)       1,498 (37.5)                548  (13.7)                  221  (5.5)               1,343 (33.7)                 344  (8.6)                          260  (6.5)                  303  (7.6)           267  (6.7)               388 (9.7)
  Change per y, %    +1.38                       (--0.10)                     +0.17                    +0.69                        +0.20                               +0.31                       +0.28                +0.17                    (--0.31)
  *r*                0.88                        --0.23                       0.46                     0.86                         0.49                                0.93                        0.90                 0.75                     --0.91
  p value†           0.002                       0.547                        0.208                    0.003                        0.179                               \<0.001                     0.001                0.020                    0.001

\*NHI, National Health Insurance; *r*, Pearson correlation coefficient. †p\<0.05 is considered statistically significant.

Our study suggests that both underlying renal disease and malignancy increased the incidence and mortality rates of pyogenic liver abscess. A previous survey in patients with end-stage renal disease showed the in-hospital prevalence of liver abscess to be 130.59/100,000 and the death rate to be 33.30% ([@R21]). Patients died of septic shock despite aggressive management in 50% of these cases. In our data, renal disease triples the incidence of pyogenic liver abscess and doubles the death rates, compatible with the previous report. Similarly, underlying malignancy had been well recognized as an important aggravating factor ([@R13]*,*[@R22]) of liver abscess. Our data also showed 10-fold and 2-fold increases in the incidence and mortality rates of pyogenic liver abscess. In addition to the fact that tumors from the hepatobiliary region might mimic abscesses ([@R23]*--*[@R25]), tumors in other regions were also associated with poor prognoses ([@R26]*,*[@R27]), confirming malignancy itself as an independent aggravating factor. Because the prevalence of both renal disease and malignancy has increased in recent years, the threat of pyogenic liver abscess in those patients is becoming more important, worthy of our special notice.

In contrast to renal disease and malignancy, the role of diabetes in mortality rates is controversial. Some reports suggested its association with a more aggressive clinical course ([@R18]*,*[@R28]) while others merely confirmed its coexistence with pyogenic liver abscess ([@R15]*,*[@R19]*,*[@R22]). In our analysis of the NHI database, diabetes caused a 9-fold increase of incidence but paradoxically decreased death rates. Further analysis in NTUH case-patients showed that such a decrease was attributed to the high proportion of *Klebsiella* spp. infection and that diabetes played no significant role in prognoses. This result is compatible with a report from a recent population-based case-control study in Denmark which stated that diabetes modified the risk but not the prognosis of pyogenic liver abscess ([@R29]). Since diabetes compromises host immune systems, its pivotal role in the risk for abscess but minimal role in abscess-related death, indicates a complicated interaction between the pathogens and the immune system of hosts. More in-depth research in this field is necessary.

The NHI database, although almost complete, is limited in 3 aspects. First, it is deficient in microbiologic data. Because the microbiologic data from NTUH is hospital-based, data might not accurately reflect the condition in the general population. Second, because it enables only 5 diagnoses for each case, coding of diagnoses might be biased if the specific case is complicated with \>5 underlying diseases. For this reason, some minor conditions, such as peptic ulcer, urinary tract infection, and hypertension, paradoxically decreased death rates in our data. Third, in contrast to the comprehensive data of pyogenic liver abscess, detailed health data for each person in the population are not available. We are therefore unable to estimate the interaction among the risk factors of pyogenic liver abscess in the population ([Table 3](#T3){ref-type="table"}). Nevertheless, this study still provides a clear picture of pyogenic liver abscess in Taiwan. The rapid and steady increase of cases with pyogenic liver abscess in Taiwan should be noted ([Table 2](#T2){ref-type="table"}). Although the prognosis of liver abscess patients has improved over time ([Figure 3](#F3){ref-type="fig"}), pyogenic liver abscess-related death in the population continues to increase ([Table 2](#T2){ref-type="table"}). Furthermore, complex interactions between pyogenic liver abscess, diabetes, renal disease, and malignancy are shown to worsen this condition. Further collaboration among clinical medical practitioners, public health workers, and research scientists is mandatory to fight against such a challenge in the future.
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